Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
13 studies found for:    GLUCOCORTICOID RECEPTOR
Show Display Options
Rank Status Study
1 Recruiting Difference in GC-induced Adrenal Insufficiency in RA Related to Polymorphisms in the Glucocorticoid Receptor Gene
Condition: Rheumatoid Arthritis
Intervention: Other: No intervention
2 Recruiting Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Condition: Mild Hypercortisolism
Intervention: Drug: Mifepristone
3 Completed Glucocorticoid Receptor Antagonism in Subclinical Cushings
Condition: Subclinical Cushing's
Intervention: Drug: Mifepristone
4 Enrolling by invitation The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic Disease
Conditions: Glucose Homeostasis;   Protein Metabolism;   Lipid Metabolism;   Respiratory Function;   Connective Tissue Metabolism
5 Recruiting Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
Condition: Borderline Personality Disorder
Interventions: Drug: mifepristone;   Drug: Placebo
6 Enrolling by invitation FCM Analysis GR in Steroid-Treatment Patients
Condition: Healthy
7 Recruiting Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: enzalutamide;   Drug: mifepristone;   Other: laboratory biomarker analysis;   Other: pharmacological study
8 Completed Effect of Symbicort on GR Localisation in Asthma
Condition: Asthma
Interventions: Procedure: Induced Sputum;   Drug: Symbicort, Formoterol, Budesonide and Placebo
9 Recruiting Safety, Tolerability and Efficacy of ISIS-GCCRRx in Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: ISIS-GCCRRx;   Drug: Placebo
10 Completed Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder
Conditions: Post-Traumatic Stress Disorders;   Healthy
11 Completed The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
Condition: Asthma
Interventions: Drug: AZD5423;   Drug: Budesonide 200 microgram;   Drug: Placebo
12 Completed Brain Receptor Function in Post-Traumatic Stress Disorder
Condition: Post-Traumatic Stress Disorder
Intervention: Drug: RU-486 (Mifepristone)
13 Recruiting Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)
Condition: Glucocorticosteroid Refractory Acute GVHD
Intervention: Drug: Toclizumab

Indicates status has not been verified in more than two years